Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiranjib Chakraborty

Showing results (1-10 of 316) with videos related to

Pageof 32
Sort By:
Current Opinion in Pharmacology|August 31, 2021
Therapeutics development for Ebola virus disease: A recent scenarioChiranjib Chakraborty
Current Protein & Peptide Science|April 14, 2006
Biochemical and molecular basis of insulin resistanceChiranjib Chakraborty
Indian Journal of Pathology & Microbiology|November 22, 2005
Overexpression for commercial production of recombinant human insulin as A-chain and B-chain fusion protein in Escherichia coli through genetically engineered plasmidsChiranjib Chakraborty
Current Drug Targets|March 14, 2007
Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencingChiranjib Chakraborty
Molecular Therapy. Nucleic Acids|September 8, 2023
The current landscape of long COVID clinical trials: NIH's RECOVER to Stanford Medicine's STOP-PASC initiativeChiranjib Chakraborty, Manojit Bhattacharya
Vaccine|November 1, 2020
India's cost-effective COVID-19 vaccine development initiativesChiranjib Chakraborty, Govindasamy Agoramoorthy
Virology|September 17, 2024
Evolution and mutational landscape of highly pathogenic avian influenza strain A(H5N1) in the current outbreak in the USA and global landscapeChiranjib Chakraborty, Manojit Bhattacharya
The Lancet. Infectious Diseases|May 27, 2015
India's budget reduction and AIDS initiativesGovindasamy Agoramoorthy, Chiranjib Chakraborty
Cell Biochemistry and Biophysics|March 16, 2013
Computational analysis of C-reactive protein for assessment of molecular dynamics and interaction propertiesChiranjib Chakraborty, Alok Agrawal
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 3, 2016
Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancersChiranjib Chakraborty, Srijit Das
Pageof 32

Showing results (1-10 of 316) with videos related to

Sort By:
Pageof 32
Current Opinion in Pharmacology|August 31, 2021
Therapeutics development for Ebola virus disease: A recent scenarioChiranjib Chakraborty
Current Protein & Peptide Science|April 14, 2006
Biochemical and molecular basis of insulin resistanceChiranjib Chakraborty
Indian Journal of Pathology & Microbiology|November 22, 2005
Overexpression for commercial production of recombinant human insulin as A-chain and B-chain fusion protein in Escherichia coli through genetically engineered plasmidsChiranjib Chakraborty
Current Drug Targets|March 14, 2007
Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencingChiranjib Chakraborty
Molecular Therapy. Nucleic Acids|September 8, 2023
The current landscape of long COVID clinical trials: NIH's RECOVER to Stanford Medicine's STOP-PASC initiativeChiranjib Chakraborty, Manojit Bhattacharya
Vaccine|November 1, 2020
India's cost-effective COVID-19 vaccine development initiativesChiranjib Chakraborty, Govindasamy Agoramoorthy
Virology|September 17, 2024
Evolution and mutational landscape of highly pathogenic avian influenza strain A(H5N1) in the current outbreak in the USA and global landscapeChiranjib Chakraborty, Manojit Bhattacharya
The Lancet. Infectious Diseases|May 27, 2015
India's budget reduction and AIDS initiativesGovindasamy Agoramoorthy, Chiranjib Chakraborty
Cell Biochemistry and Biophysics|March 16, 2013
Computational analysis of C-reactive protein for assessment of molecular dynamics and interaction propertiesChiranjib Chakraborty, Alok Agrawal
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 3, 2016
Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancersChiranjib Chakraborty, Srijit Das
Pageof 32